|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/395 | |||
| C07K 16/18 | |||
| C07K 16/28 |
| (11) | Patento numeris | 2611464 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11820900.6 |
| Europos patento paraiškos padavimo data | 2011-09-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-07-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/050439 |
| Data | 2011-09-02 |
| (87) | Numeris | WO 2012/031273 |
| Data | 2012-03-08 |
| (30) | Numeris | Data | Šalis |
| 380181 P | 2010-09-03 | US |
| (72) |
DYLLA, Scott J., US
FOORD, Orit, US
STULL, Robert A., US
ANDERSON, Wade C., US
OHSHIMA, Saiyou, US
|
| (73) |
AbbVie Stemcentrx LLC,
1 North Waukegan Road, North Chicago, IL 60064-6400,
US
|
| (54) | NOVEL MODULATORS AND METHODS OF USE |
| NOVEL MODULATORS AND METHODS OF USE |